Doctor profile · Federal record
Dr. PAUL NGUYEN, M.D.
Addiction Medicine (Psychiatry & Neurology) Physician (CMS: PSYCHIATRY) · Psychiatry Physician · N LAS VEGAS, NV
- NPI 1740497346
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2031 MCDANIEL ST STE 230
N LAS VEGAS, NV 890306309
(702) 405-9080
fax (702) 405-9240 - Mailing address
-
PO BOX 36830
LAS VEGAS, NV 891336830
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- November 27, 2017
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 2084A0401X — NUCC code
- State license (1)
- Nevada #12178
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740497346. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,994
Distinct HCPCS
7
Medicare allowed
$248,029
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,628 | 210 | $90 | |
Q3014 |
Telehealth originating site facility fee | 1,586 | 191 | $28 | |
99415 |
Extended office or other outpatient service by clinical staff, first hour | 290 | 35 | $19 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 243 | 121 | $127 | |
99348 |
Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | 115 | 32 | $76 | |
96372 |
Injection of drug or substance under skin or into muscle | 82 | 13 | $14 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 50 | 50 | $219 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 570. This provider delivers 7.0× the peer median.Open Payments
Industry payments received
All-time total
$2,028
Transactions
119
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $491.66 | |
| Otsuka America Pharmaceutical, Inc. | 28 | $389.54 | |
| Alkermes, Inc. | 19 | $319.84 | |
| ABBVIE INC. | 15 | $287.10 | |
| Supernus Pharmaceuticals, Inc. | 14 | $156.00 | |
| Neurocrine Biosciences, Inc. | 9 | $145.70 | |
| Teva Pharmaceuticals USA, Inc. | 8 | $140.39 | |
| Janssen Pharmaceuticals, Inc | 2 | $42.89 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $35.61 | |
| Vanda Pharmaceuticals Inc. | 1 | $19.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
5,810
Patients
882
Total drug cost
$76,693
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trazodone Hcl | Generic | 892 | 134 | $10,134 |
| Buspirone Hcl | Generic | 650 | 109 | $9,045 |
| Quetiapine Fumarate | Generic | 631 | 89 | $14,064 |
| Alprazolam | Generic | 535 | 69 | $4,257 |
| Sertraline Hcl | Generic | 426 | 59 | $2,925 |
| Bupropion Hcl Sr (Bupropion Hcl) | Brand | 344 | 54 | $5,307 |
| Duloxetine Hcl | Generic | 310 | 46 | $4,592 |
| Risperidone | Generic | 304 | 46 | $4,660 |
| Oxcarbazepine | Generic | 280 | 49 | $8,401 |
| Clonazepam | Generic | 259 | 44 | $1,799 |